发明授权
- 专利标题： Substituted annulated triazines and use thereof
- 专利标题（中）： 取代的环状三嗪及其用途
-
申请号： US14738148申请日： 2015-06-12
-
公开(公告)号： US09505786B2公开(公告)日： 2016-11-29
- 发明人: Markus Follmann , Johannes-Peter Stasch , Gorden Redlich , Nils Griebenow , Dieter Lang , Frank Wunder , Walter Hübsch , Alexandros Vakalopoulos , Adrian Tersteegen
- 申请人： BAYER INTELLECTUAL PROPERTY GMBH , BAYER PHARMA AKTIENGESELLSCHAFT
- 申请人地址： DE Berlin DE Monheim
- 专利权人： BAYER PHARMA AKTIENGESELLSCHAFT,BAYER INTELLECTUAL PROPERTY GMBH
- 当前专利权人： BAYER PHARMA AKTIENGESELLSCHAFT,BAYER INTELLECTUAL PROPERTY GMBH
- 当前专利权人地址： DE Berlin DE Monheim
- 代理机构： Buchanan Ingersoll & Rooney PC
- 优先权： DE102012200349 20120111
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/53 ; A61P9/10 ; A61P9/12 ; A61P7/02 ; C07D519/00 ; A61K31/519 ; A61K45/06
摘要：
The present application relates to novel substituted fused pyrimidines and triazines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.
公开/授权文献
- US20150274754A1 SUBSTITUTED ANNULATED TRIAZINES AND USE THEREOF 公开/授权日：2015-10-01
信息查询
